2014 Pediatric Epilepsies Award LOI
Eligibility: Eligibility: This award is available to both established and early career investigators* exploring cutting-edge approaches to curing the pediatric epilepsies. Preference will be given to research addressing the more severe and refractory epilepsies. International applicants are welcome. Researchers who serve on CURE’s Scientific Advisory Board are ineligible to apply for or sponsor a grant for the duration of their term. All materials must be submitted in English. * Generally, early career investigators are university faculty at the assistant professor level (or hold an equivalent position in a non-university research organization). Established investigators are university faculty at the associate professor level or above.
Amount (USD): $250,000.00
Application Deadline: 1/15/14
Areas of Interest: Pediatrics
Related Link: http://www.CUREepilepsy.org/research/apply.asp
Duration (yrs): 2
Application Information: There are many known epilepsy syndromes that occur in the pediatric population. These epilepsies are often debilitating and difficult to treat with currently available therapies. CURE seeks novel research projects of relevance to any or all pediatric epilepsies, including: (1) the cellular, molecular, and systems-level understanding of the underlying pathogenic mechanisms; (2) investigations of the impact, natural history, and epidemiology; and (3) novel treatments which may impact progression of the disease. CURE specifically encourage studies that may not be currently fundable by other agencies, such as the NIH, because of their preliminary or unconventional nature. CURE also strongly encourages collaborative projects, especially those that are inclusive of investigators and expertise from fields outside of epilepsy.
Other: 2014 FUNDING CYCLE Deadline for Receipt of LOI: January 15, 2014 Full Application Invitations: February 28, 2014 Deadline for Receipt of Full Application: May 1, 2014 Award Announcement: July 2014 Earliest Project Start Date: August 1, 2014 Letter of Intent: All applicants must submit a Letter of Intent (LOI). The LOI should clearly and succinctly outline the hypothesis and specific aims, and provide a brief description of how the proposed research plan, if successful, meets the goals of the Pediatric Epilepsies Award. All LOIs are evaluated by scientific reviewers and the Lay Review Council for innovation, feasibility, scientific merit, relevance to CURE’s mission and likeliness to be transformative. Final decisions as to who will be invited to submit formal proposals will be made by the CURE Board of Directors. Questions regarding these guidelines are welcome and should be directed to Tracy Dixon-Salazar at Tracy@CUREepilepsy.org or 312-255-1801.